Detalles de la búsqueda
1.
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.
Cytokine
; 157: 155934, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35709568
2.
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.
Respir Res
; 23(1): 202, 2022 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945604
3.
A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19.
Sci Transl Med
; 15(710): eadi0252, 2023 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611083
4.
Isolation of Conventional Murine Lung Dendritic Cell Subsets.
Methods Mol Biol
; 2506: 237-255, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35771476
5.
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.
Cell Rep Med
; 3(12): 100833, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459994
6.
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
J Exp Med
; 219(2)2022 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914824
7.
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.
Lancet Respir Med
; 9(12): 1427-1438, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34756178
8.
Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 556, 2020 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32571394
9.
Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 554, 2020 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32571428
10.
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 468, 2020 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32493441
11.
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 491, 2020 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32503663
12.
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.
Front Immunol
; 11: 596761, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33329586
13.
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 934, 2020 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213529
Resultados
1 -
13
de 13
1
Próxima >
>>